BCX7353

· BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BCX7353, covering 2016-01-13 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: A Long Term Safety Study of BCX7353 in Hereditary Angioedema [Phase 2, Phase 3]